Popular on s4story
- People & Stories/Gente y Cuentos Announces New Board Leadership & Corporate Partnership Initiative - 135
- Mensa identifies best board games of 2025 - 130
- Electives Appoints DraftKings' CPO Linda Aiello to Board Amid Record Quarter - 106
- Is Billboard Advertising Still Effective in 2025?
- Two exciting new fantasy & adventure books are published
- Mission 3A Establishes Healthcare Advisory Board with Addition of Industry Leaders Patrick Fisher, Kevin Cordell, and Dr. Greg Berlet
- MAJOR New release of Krypto500 (ELF-HF) Sigint - COMINT software
- "The Eyes Have It" a Short Story by Philip K. Dick Now Available on Audiobook
- Fairfield Inn by Marriott Scottsdale Old Town Opens
- New Build-to-Suit VA Medical Office Facility Coming to Highland Heights, KY
Similar on s4story
- PBK Miner completes $80 million Series B financing to support AI cloud mining and increase user investment return by 25%
- Asset-Backed Green Crypto: Fueling the Trillion-Dollar Revolution
- NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3
- Cybersecurity is Protecting Your Personal Information and Your Portfolio
- The Paris Court of International Arbitration Elects Dr. John J. Maalouf as its New President
- $56.7 Million Announced in Q1 2025 with Revenue Growth and Progress Toward NASDAQ Uplisting for AI Marketing Company: IQSTEL, Inc. Stock Symbol: IQSTD
- SAVVY MINING raised $500 million and launched BTC.XRP.DOGE cloud mining, increasing investors' returns by 30%
- Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
- Jay Tapp was named Managing Director in British Columbia
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Integra LifeSciences Holdings Corp. (IART)
S For Story/10587931
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Integra LifeSciences Holdings Corp. ("Integra" or the "Company") (NASDAQ: IART). The investigation concerns whether Integra and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
Integra operates as a holding company that, through its subsidiaries, provides solutions in orthopedic surgery, neurosurgery, and reconstructive and general surgery.
On May 23, 2023, Integra announced that it had conducted an internal investigation, leading to a global recall of all products produced at its Boston, Massachusetts facility. The affected products were distributed between March 1, 2018, and May 22, 2023. The company ceased manufacturing operations at the facility. The reason behind these actions was the company "identified deviations with endotoxin testing that may have resulted in the release of products with higher levels of endotoxins than permitted by the product specifications." Integra disclosed that it anticipates a material impairment charge related to the write-off of inventories. As a consequence, the company revised its revenue and earnings per share guidance lower than previously stated. On this news, the price of Integra shares declined by $10.24 per share, or approximately 20.19%, from $50.72 per share to close at $40.48 on May 23, 2023.
More on S For Story
If you purchased or otherwise acquired Integra securities, have information, or would like to learn more about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.
Kirby McInerney LLP is a New York-based plaintiffs' law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm's efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP's website: http://www.kmllp.com.
More on S For Story
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com
Integra operates as a holding company that, through its subsidiaries, provides solutions in orthopedic surgery, neurosurgery, and reconstructive and general surgery.
On May 23, 2023, Integra announced that it had conducted an internal investigation, leading to a global recall of all products produced at its Boston, Massachusetts facility. The affected products were distributed between March 1, 2018, and May 22, 2023. The company ceased manufacturing operations at the facility. The reason behind these actions was the company "identified deviations with endotoxin testing that may have resulted in the release of products with higher levels of endotoxins than permitted by the product specifications." Integra disclosed that it anticipates a material impairment charge related to the write-off of inventories. As a consequence, the company revised its revenue and earnings per share guidance lower than previously stated. On this news, the price of Integra shares declined by $10.24 per share, or approximately 20.19%, from $50.72 per share to close at $40.48 on May 23, 2023.
More on S For Story
- San Diego Author Debuts Thrilling Time-Travel Novel
- Orlando 9-Year-Old Publishes Original Sequel to The Wonderful Wizard of Oz
- Inspiring memoir about growing up well with good support & guidance
- Historical Fantasy 'Keeper of the Hollow' Weaves Faith, Mystery, and Mountain Magic
- Fairmint Introduces First Fully Onchain and Open Cap Table Infrastructure
If you purchased or otherwise acquired Integra securities, have information, or would like to learn more about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.
Kirby McInerney LLP is a New York-based plaintiffs' law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm's efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP's website: http://www.kmllp.com.
More on S For Story
- Vortex Brands Begins Gold Purchases Under New Joint Venture with Dubai-Based Partner
- I Turned Mom into a Popsicle! Hits the Shelves
- NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3
- Aureli Construction Sets the Standard for Seamless Home Additions in Greater Boston
- Do You Know Why Nobody Sits Like the French?
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com
Filed Under: Business
0 Comments
Latest on S For Story
- Sci-Fi Author Christian Hurst on Creativity, Resilience, and Making Art Anyway
- Fray Fitness Launches Memorial Day Sale and Veteran Organization Giveaway
- ABM for Good™ Launches First Project with Build Change
- ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management
- Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
- Jay Tapp was named Managing Director in British Columbia
- Hubei Heavy Equipment Makes a Striking Appearance at CIMT and Competes with International Brands
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
- NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
- Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
- DuoKey, Axiomtek and Blue Edge Network Partner to Enhance Smart Cities with Privacy-Preserving Urban Safeguarding and Fleet Management
- Arlina A.'s A LETTER TO PAWTONE Explores Childhood Innocence and the Moments That Shape Us
- Austin Keen Joins WakeFX RopePal as Official Brand Ambassador
- Bonelli Systems Expands Managed IT Services Nationwide, Leveraging Microsoft Azure Expertise
- $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
- Whistleblower Claims Dental Patient Deaths Likely Due to Book Ban
- xREnergy up as much as +3,094,634% on first day listed on the XRP Ledger. Ticker : $XRE
- Psychiatry's Legacy of Racism and Coercion Highlighted in Restraint Deaths
- New Book 'Cybersecurity Leadership' Guides SME Leaders to Make Smart, Strategic Security Decisions
- "Stop scrolling and start watching" - Beloved film recommendation site Criticker gets a major makeover